Adverse Events Monitoring, Pharmacovigilance and Risk Management

Adverse Events Monitoring, Pharmacovigilance and Risk Management - September 2014
by Howard L. Dorfman, Senior Vice President and General Counsel at Turing Pharmaceuticals, David L. Rosen, Partner at Foley & Lardner LLP

Part of

Session: Adverse Events Monitoring, Pharmacovigilance and Risk Management

Part of Conference:

September 18 – 19, 2014

Boston, MA

Purchase Products